Alessandro Bonifazi

Associate Professor

University of Texas Medical Branch at Galveston

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Collaborators (13)

Hideaki Yano

Northeastern University

UNITED STATES

View details

Alessandro Piergentili

University of Camerino

ITALY

View details

Zheng-Xiong Xi

National Institute on Drug Abuse Intramural Research Program

UNITED STATES

View details

Wilma Quaglia

ITALY

View details

Maria Vittoria Micioni Di Bonaventura

Assistant Professor of Pharmacology

Università degli Studi di Perugia Dipartimento di Scienze Farmaceutiche

ITALY

View details

Fabio Del Bello

University of Camerino

ITALY

View details

Meritxell Canals

Professor at School of Life Sciences

University of Nottingham

UNITED KINGDOM

View details

Carlo Cifani

ITALY

View details

Gianfabio Giorgioni

Assistant Professor

University of Camerino

ITALY

View details

Maria Giovanna Sabbieti

ITALY

View details

Vsevolod Katritch

University of Southern California

UNITED STATES

View details

Emanuela Micioni Di Bonaventura

ITALY

View details

J. Robert Lane

Associate Professor in Molecular Pharmacology

University of Nottingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alessandro Bonifazi

Research Interests

Explore related searches

Contact this professor

Articles (10)

Involvement of dopamine D3 receptor in impulsive choice decision-making in male rats

A bitopic agonist bound to the dopamine 3 receptor reveals a selectivity site

Linkers in Bitopic Agonists Shape Bias Profile among Transducers for the Dopamine D2 and D3 Receptors

Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands

Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D3 (D3R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics

Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders

The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior

Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders

Highly Potent and Selective Dopamine D<sub>4</sub> Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma.

Chiral Cyclic Aliphatic Linkers as Building Blocks for Selective Dopamine D2 or D3 Receptor Agonists

Collaborators (13)

Hideaki Yano

Alessandro Piergentili

Zheng-Xiong Xi

Wilma Quaglia

Maria Vittoria Micioni Di Bonaventura

Fabio Del Bello

Meritxell Canals

Carlo Cifani

Gianfabio Giorgioni

Maria Giovanna Sabbieti

Vsevolod Katritch

Emanuela Micioni Di Bonaventura

J. Robert Lane

Make your next move.